Let's take a little bit of a deeper dive than we normally do on these segments into the coronavirus response, the pandemic response, the specifically the United States.

Most people remember President Trump at the beginning standing at a podium, you had Fauci behind him, you had this government response, you had the lab coats, the doctors, the vaccine manufacturers, FDA, all promising transparency.

But, Bob, it was a medical health agency response with the government.

But there was a separate response running parallel to that, and it was by the military. This military complex was also in there running this COVID response.

And for people that may not have seen it, this is what it looked like on December 12, 2020, when the FDA had just green-lighted Pfizer's COVID shot for emergency use authorization, and it was time to roll it out.

Let's look at the military was saying.

We checked our egos at the door. We worked collectively to solve the problem, and we have achieved success, as was identified last night by the FDA when they approved EUA of the Pfizer vaccine.

Now we'll begin distribution of safe and effective vaccines to the American people.

You have heard me refer to today as D-Day. Some people assume that I meant day of distribution. In fact, D-Day in military designates the day the mission begins.

D-Day was a pivotal turning point in World War II. It was the beginning of the end. D-Day was the beginning of the end, and that's where we are today.

And that was General Gustav Perna. He was directing the distribution of Operation Warp Speed. But you can see there that there is a military flare to that.

If this was the only video someone saw from the past looking back in history, they'd say, wow, this really looks like the military was commanding this thing.

And even before the coronavirus, a couple of years before that, we saw the military starting to get into collaboration with the FDA.

Here's an article from 2017 in November, almost two years before we're actually knowing about the coronavirus.

FDA and Pentagon interfor over product approval. And what they were talking about there was emergency use authorization products.

The Pentagon, the Department of Defense, wanted really control over the emergency use authorization mechanism for times of war, times of biological attacks.

They wanted people to fast track that on their own. And the FDA hats off to them at that point. They actually did put down their foot and said, no, this is our wheelhouse.

We want to remain control on this. So what happened was there was a compromise. Public law 115-92, cemented public law.

And if we go into this and we look at it at the time, and then again, this 2017, this was an act to amend the Federal Food Drug and Cosmetic Act to authorize additional emergency uses for medical products to reduce deaths and severity of injuries caused by age damage.

These caused by agents of war and for other purposes. And right after that, there was a great article on this that broke it down really with the legal ease and how it really affected the future of EUAs.

And this article, if anybody wants to look at this, this really breaks it down. A new era of collaboration between the Department of Defense and the FDA.

This thing is moving a little bit. It says a compromise emerged between the positions of the DOD and FDA, whereby DOD would get both the expansion of the EUA authority beyond CBRN. That's chemical, biological, radiological, and nuclear threats for battlefield, trauma care, and expedited approval mechanism for DOD medical priorities.

...